Eloxx Pharmaceuticals Inc. (ELOX) OTC MARKETS
$0.81 - (-)
Market Cap: -
As of 04/24/24 12:00 AM EDT. Market open.
Eloxx Pharmaceuticals Inc. (ELOX)
OTC MARKETS
$0.81
- (-)
Market Cap: -
As of 04/24/24 12:00 AM EDT. Market open.
Add to Portfolio
eloxx pharmaceuticals, inc. is a clinical-stage biopharmaceutical company developing novel rna-modulating drug candidates that are designed to treat rare and ultra-rare premature stop codon diseases. premature stop codons are point mutations that disrupt protein synthesis from messenger rna. as a consequence, patients with premature stop codon diseases have reduced or eliminated protein ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
CEO
Robert Ward
Full Time Employees
26
CEO Compensation (Base)
$452,885
CEO Compensation (Total)
$903,644
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
CEO
Robert Ward
Full Time Employees
26
CEO Compensation (Base)
$452,885
CEO Compensation (Total)
$903,644
Address
950 Winter St, Massachusetts, Waltham, 02451-1424.
PRICE CHART FOR ELOXX PHARMACEUTICALS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$3.97
Previous Close
$0.81
Days Range
$0.80 - $0.84
52 week range
- - -
Volume
92,763
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
3,143,390
Open
$3.97
Previous Close
$0.81
Days Range
$0.80 - $0.84
52 week range
- - -
Volume
92,763
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
3,143,390
FINANCIAL STATEMENTS FOR ELOXX PHARMACEUTICALS INC
LOADING...
INSIDER TRANSACTIONS FOR ELOXX PHARMACEUTICALS INC
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Aggarwal Sumit | PRESIDENT AND CEO | Dec 01, 2021 | Option Exercise | $0.72 | 81,933 | 58,992 | 197,225 | Dec 03, 2021, 05:15 PM |
MODUR VIJAY | HEAD OF R&D | Dec 01, 2021 | Option Exercise | $0.72 | 64,373 | 46,349 | 154,953 | Dec 03, 2021, 05:14 PM |
Geffken Daniel E. | INTERIM CFO | Nov 29, 2021 | Buy | $0.72 | 50,000 | 36,000 | 50,000 | Dec 01, 2021, 11:06 AM |
Belloff Neil S. | COO, GENERAL COUNSEL &CORP SEC | Jul 30, 2021 | Option Exercise | $1.32 | 459 | 606 | 32,699 | Jul 30, 2021, 08:32 PM |
Belloff Neil S. | COO, GENERAL COUNSEL &CORP SEC | May 25, 2021 | Option Exercise | $1.39 | 1,835 | 2,551 | 31,595 | May 26, 2021, 04:10 PM |
PAREKH RAJESH B | Director | May 13, 2021 | Buy | $1.35 | 2,466,666 | 3,329,999 | 4,827,129 | May 17, 2021, 09:22 AM |
Belloff Neil S. | COO, GENERAL COUNSEL &CORP SEC | Apr 30, 2021 | Option Exercise | $2.18 | 459 | 1,001 | 27,180 | May 03, 2021, 10:15 AM |
Belloff Neil S. | COO, GENERAL COUNSEL &CORP SEC | Feb 25, 2021 | Option Exercise | $3.95 | 7,338 | 28,985 | 26,077 | Feb 26, 2021, 07:05 PM |
Williams Gregory C. | CHIEF EXECUTIVE OFFICER | Feb 25, 2021 | Option Exercise | $3.95 | 15,360 | 60,672 | 44,629 | Feb 26, 2021, 07:05 PM |
Belloff Neil S. | COO, GENERAL COUNSEL &CORP SEC | Jan 30, 2021 | Option Exercise | $3.44 | 542 | 1,864 | 8,415 | Feb 02, 2021, 04:10 PM |
Williams Gregory C. | CHIEF EXECUTIVE OFFICER | Jan 30, 2021 | Option Exercise | $3.44 | 643 | 2,212 | 9,989 | Feb 02, 2021, 04:10 PM |
Williams Gregory C. | CHIEF EXECUTIVE OFFICER | Oct 30, 2020 | Option Exercise | $2.53 | 625 | 1,581 | 8,757 | Nov 02, 2020, 04:20 PM |
Belloff Neil S. | COO, GENERAL COUNSEL &CORP SEC | Oct 30, 2020 | Option Exercise | $2.53 | 459 | 1,161 | 7,394 | Nov 02, 2020, 04:20 PM |
Belloff Neil S. | COO, GENERAL COUNSEL &CORP SEC | Jul 30, 2020 | Option Exercise | $2.84 | 459 | 1,304 | 6,291 | Jul 31, 2020, 04:10 PM |
Williams Gregory C. | CHIEF EXECUTIVE OFFICER | Jul 30, 2020 | Option Exercise | $2.84 | 576 | 1,636 | 7,507 | Jul 31, 2020, 04:10 PM |
Williams Gregory C. | CHIEF EXECUTIVE OFFICER | Apr 30, 2020 | Option Exercise | $2.92 | 577 | 1,685 | 6,208 | May 01, 2020, 05:20 PM |
Belloff Neil S. | COO, GENERAL COUNSEL &CORP SEC | Apr 30, 2020 | Option Exercise | $2.92 | 459 | 1,340 | 5,187 | May 01, 2020, 05:20 PM |
WEAVER GREGORY L | FORMER CHIEF FINANCIAL OFFICER | Mar 15, 2020 | Option Exercise | $2.85 | 1,086 | 3,095 | 10,431 | Mar 16, 2020, 04:10 PM |
Belloff Neil S. | COO, GENERAL COUNSEL &CORP SEC | Jan 30, 2020 | Option Exercise | $3.91 | 2,166 | 8,469 | 4,084 | Mar 04, 2020, 02:30 PM |
Snow David P. | FORMER CHIEF BUSINESS OFFICER | Jan 30, 2020 | Option Exercise | $3.91 | 2,045 | 7,996 | 4,205 | Mar 04, 2020, 02:30 PM |
Williams Gregory C. | CHIEF EXECUTIVE OFFICER | Jan 30, 2020 | Option Exercise | $3.91 | 2,590 | 10,127 | 4,910 | Mar 04, 2020, 02:30 PM |
WEAVER GREGORY L | CHIEF FINANCIAL OFFICER | Jan 30, 2020 | Option Exercise | $3.91 | 1,733 | 6,776 | 7,767 | Mar 04, 2020, 02:30 PM |
Snow David P. | FORMER CHIEF BUSINESS OFFICER | Feb 29, 2020 | Option Exercise | $3.13 | 1,534 | 4,801 | 7,359 | Mar 03, 2020, 06:30 PM |
Ward Robert | FORMER CHAIRMAN AND CEO | Feb 29, 2020 | Option Exercise | $3.13 | 23,285 | 72,882 | 244,267 | Mar 03, 2020, 06:30 PM |
WEAVER GREGORY L | CHIEF FINANCIAL OFFICER | Jan 30, 2020 | Option Exercise | $3.91 | 1,733 | 6,776 | 7,767 | Jan 31, 2020, 05:26 PM |
Williams Gregory C. | CHIEF OPERATING OFFICER | Jan 30, 2020 | Option Exercise | $3.91 | 2,590 | 10,127 | 4,910 | Jan 31, 2020, 05:15 PM |
Snow David P. | CHIEF BUSINESS OFFICER | Jan 30, 2020 | Option Exercise | $3.91 | 2,045 | 7,996 | 4,205 | Jan 31, 2020, 05:15 PM |
Belloff Neil S. | GENERAL COUNSEL/CORPORATE SECR | Jan 30, 2020 | Option Exercise | $3.91 | 2,166 | 8,469 | 4,084 | Jan 31, 2020, 05:15 PM |
Ward Robert | CHAIRMAN AND CEO | Dec 26, 2019 | Option Exercise | $7.26 | 15,806 | 114,752 | 190,746 | Dec 27, 2019, 04:10 PM |
Ward Robert | CHAIRMAN AND CEO | Sep 26, 2019 | Option Exercise | $4.37 | 10,467 | 45,741 | 170,953 | Sep 27, 2019, 04:10 PM |
Ward Robert | CHIEF EXECUTIVE OFFICER | Jun 26, 2019 | Option Exercise | $9.03 | 10,467 | 94,517 | 145,821 | Jun 27, 2019, 05:39 PM |
Nussbaum Ran | Director | Jun 24, 2019 | Buy | $9.00 | 200,000 | 1,800,000 | 1,049,310 | Jun 26, 2019, 04:51 PM |
Kariv Tomer | Director | Jun 24, 2019 | Buy | $9.00 | 200,000 | 1,800,000 | 1,049,310 | Jun 26, 2019, 04:48 PM |
Pontifax Management 4 G.P. (2015) Ltd. | 10% Owner | Jun 24, 2019 | Buy | $9.00 | 200,000 | 1,800,000 | 1,049,310 | Jun 26, 2019, 04:44 PM |
Ward Robert | CHIEF EXECUTIVE OFFICER | Mar 26, 2019 | Option Exercise | $11.50 | 10,467 | 120,371 | 120,689 | Mar 28, 2019, 04:15 PM |
Ward Robert | CHIEF EXECUTIVE OFFICER | Dec 26, 2018 | Option Exercise | $12.60 | 83,038 | 1,046,279 | 145,557 | Dec 28, 2018, 04:15 PM |
Noiman Silvia | Chief Executive Officer | Jun 06, 2018 | Option Exercise | $0.00 | 349,400 | 210 | 490,789 | Jun 29, 2018, 04:12 PM |
Ward Robert | Chief Executive Officer | May 22, 2018 | Buy | $14.34 | 5,000 | 71,700 | 15,000 | May 23, 2018, 04:17 PM |
Shabtai Gilad | 10% Owner | Apr 30, 2018 | Buy | $9.75 | 75,000 | 731,250 | 3,351,770 | May 01, 2018, 04:39 PM |
Pontifax Management 4 G.P. (2015) Ltd. | 10% Owner | Apr 30, 2018 | Buy | $9.75 | 350,000 | 3,412,500 | 962,504 | May 01, 2018, 04:37 PM |
Nussbaum Ran | Director | Apr 30, 2018 | Buy | $9.75 | 350,000 | 3,412,500 | 962,504 | May 01, 2018, 04:34 PM |
Kleijwegt Martijn | Director | Apr 30, 2018 | Buy | $9.75 | 300,000 | 2,925,000 | 2,953,673 | May 01, 2018, 04:32 PM |
Kariv Tomer | Director | Apr 30, 2018 | Buy | $9.75 | 350,000 | 3,412,500 | 962,504 | May 01, 2018, 04:31 PM |
Shabtai Gilad | 10% Owner | Apr 04, 2018 | Buy | $9.58 | 2,600 | 24,908 | 3,276,770 | Apr 05, 2018, 06:08 PM |
Shabtai Gilad | 10% Owner | Apr 03, 2018 | Buy | $9.41 | 5,700 | 53,637 | 3,274,170 | Apr 05, 2018, 06:08 PM |
Shabtai Gilad | 10% Owner | Mar 29, 2018 | Buy | $9.64 | 4,500 | 43,380 | 3,268,470 | Apr 02, 2018, 05:43 PM |
Avnur Zafrira | Director | Mar 26, 2018 | Buy | $9.49 | 2,000 | 18,980 | 2,263 | Mar 28, 2018, 04:37 PM |
Ward Robert | Chief Executive Officer | Mar 23, 2018 | Buy | $8.99 | 10,000 | 89,900 | 10,000 | Mar 26, 2018, 05:13 PM |
WEAVER GREGORY L | Chief Financial Officer | Mar 23, 2018 | Buy | $8.56 | 4,500 | 38,520 | 4,500 | Mar 26, 2018, 05:11 PM |
Nussbaum Ran | Director | Mar 22, 2018 | Buy | $8.00 | 6,000 | 48,000 | 789,878 | Mar 23, 2018, 04:20 PM |
Nussbaum Ran | Director | Mar 21, 2018 | Buy | $7.55 | 6,600 | 49,830 | 786,919 | Mar 23, 2018, 04:20 PM |
Kariv Tomer | Director | Mar 22, 2018 | Buy | $8.00 | 6,000 | 48,000 | 789,878 | Mar 23, 2018, 04:18 PM |
Kariv Tomer | Director | Mar 21, 2018 | Buy | $7.55 | 6,600 | 49,830 | 786,919 | Mar 23, 2018, 04:18 PM |
Pontifax Management 4 G.P. (2015) Ltd. | 10% Owner | Mar 21, 2018 | Buy | $7.55 | 6,600 | 49,830 | 786,919 | Mar 23, 2018, 04:16 PM |
Pontifax Management 4 G.P. (2015) Ltd. | 10% Owner | Mar 22, 2018 | Buy | $8.00 | 6,000 | 48,000 | 789,878 | Mar 23, 2018, 04:16 PM |
Avnur Zafrira | Director | Mar 21, 2018 | Buy | $7.60 | 263 | 1,999 | 263 | Mar 22, 2018, 07:18 PM |
Opko Health, Inc. | 10% Owner | Aug 10, 2017 | Option Exercise | $0.10 | 4,126,822 | 412,682 | 14,643,838 | Aug 14, 2017, 05:15 PM |
FROST PHILLIP MD ET AL | Director | Sep 29, 2015 | Buy | $0.61 | 35,000 | 21,350 | 1,598,170 | Oct 01, 2015, 04:47 PM |
Browne Leslie J | President and CEO | Dec 19, 2013 | Buy | $4.15 | 800 | 3,320 | 1,290 | Dec 20, 2013, 01:09 PM |
Browne Leslie J | President and CEO | May 20, 2013 | Buy | $0.04 | 30,000 | 1,200 | 49,000 | May 21, 2013, 09:59 AM |
FORBES CHRISTOPHER | Director | Nov 26, 2012 | Buy | $0.16 | 2,500 | 400 | 12,757,318 | Nov 26, 2012, 04:45 PM |
RECTOR DAVID | Director | Nov 21, 2012 | Buy | $0.16 | 38,000 | 5,890 | 352,785 | Nov 26, 2012, 06:11 AM |
FORBES CHRISTOPHER | Director | Aug 08, 2012 | Option Exercise | $0.26 | 4,292,583 | 1,116,072 | 12,754,818 | Oct 05, 2012, 03:26 PM |
Waksal Harlan | Director | Aug 08, 2012 | Option Exercise | $0.26 | 858,517 | 223,214 | 2,805,750 | Oct 05, 2012, 03:24 PM |
Browne Leslie J | President and CEO | Mar 29, 2012 | Buy | $0.26 | 10,000 | 2,600 | 19,000 | Mar 30, 2012, 09:53 AM |
Waksal Harlan | Director | Jan 06, 2012 | Buy | $0.26 | 961,538 | 250,000 | 1,902,590 | Jan 19, 2012, 03:22 PM |
FORBES CHRISTOPHER | Director | Jan 06, 2012 | Buy | $0.26 | 192,308 | 50,000 | 8,239,021 | Jan 19, 2012, 03:22 PM |
RECTOR DAVID | Director | Dec 07, 2011 | Buy | $0.24 | 44,039 | 10,402 | 314,785 | Dec 08, 2011, 05:06 PM |
RECTOR DAVID | Director | Jun 13, 2011 | Buy | $0.27 | 20,000 | 5,400 | 270,746 | Jun 14, 2011, 04:29 PM |
FORBES CHRISTOPHER | Director | Mar 22, 2011 | Buy | $0.28 | 15,000 | 4,191 | 7,452,289 | Mar 23, 2011, 08:52 AM |
Browne Leslie J | President and CEO | Mar 21, 2011 | Buy | $0.27 | 3,000 | 805 | 9,000 | Mar 22, 2011, 02:56 PM |
Browne Leslie J | President and CEO | Feb 24, 2011 | Buy | $0.29 | 3,000 | 865 | 6,000 | Feb 24, 2011, 01:36 PM |
Browne Leslie J | President and CEO | Feb 23, 2011 | Buy | $0.29 | 3,000 | 856 | 3,000 | Feb 24, 2011, 01:36 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
Aggarwal Sumit | PRESIDENT AND CEO | 12/01/2021 | 58,992 |
MODUR VIJAY | HEAD OF R&D | 12/01/2021 | 46,349 |
Geffken Daniel E. | INTERIM CFO | 11/29/2021 | 36,000 |
Belloff Neil S. | COO, GENERAL COUNSEL &CORP SEC | 07/30/2021 | 606 |
Belloff Neil S. | COO, GENERAL COUNSEL &CORP SEC | 05/25/2021 | 2,551 |
PAREKH RAJESH B | Director | 05/13/2021 | 3,329,999 |
Belloff Neil S. | COO, GENERAL COUNSEL &CORP SEC | 04/30/2021 | 1,001 |
Belloff Neil S. | COO, GENERAL COUNSEL &CORP SEC | 02/25/2021 | 28,985 |
Williams Gregory C. | CHIEF EXECUTIVE OFFICER | 02/25/2021 | 60,672 |
Belloff Neil S. | COO, GENERAL COUNSEL &CORP SEC | 01/30/2021 | 1,864 |
Williams Gregory C. | CHIEF EXECUTIVE OFFICER | 01/30/2021 | 2,212 |
Williams Gregory C. | CHIEF EXECUTIVE OFFICER | 10/30/2020 | 1,581 |
Belloff Neil S. | COO, GENERAL COUNSEL &CORP SEC | 10/30/2020 | 1,161 |
Belloff Neil S. | COO, GENERAL COUNSEL &CORP SEC | 07/30/2020 | 1,304 |
Williams Gregory C. | CHIEF EXECUTIVE OFFICER | 07/30/2020 | 1,636 |
Williams Gregory C. | CHIEF EXECUTIVE OFFICER | 04/30/2020 | 1,685 |
Belloff Neil S. | COO, GENERAL COUNSEL &CORP SEC | 04/30/2020 | 1,340 |
WEAVER GREGORY L | FORMER CHIEF FINANCIAL OFFICER | 03/15/2020 | 3,095 |
Belloff Neil S. | COO, GENERAL COUNSEL &CORP SEC | 01/30/2020 | 8,469 |
Snow David P. | FORMER CHIEF BUSINESS OFFICER | 01/30/2020 | 7,996 |
Williams Gregory C. | CHIEF EXECUTIVE OFFICER | 01/30/2020 | 10,127 |
WEAVER GREGORY L | CHIEF FINANCIAL OFFICER | 01/30/2020 | 6,776 |
Snow David P. | FORMER CHIEF BUSINESS OFFICER | 02/29/2020 | 4,801 |
Ward Robert | FORMER CHAIRMAN AND CEO | 02/29/2020 | 72,882 |
WEAVER GREGORY L | CHIEF FINANCIAL OFFICER | 01/30/2020 | 6,776 |
Williams Gregory C. | CHIEF OPERATING OFFICER | 01/30/2020 | 10,127 |
Snow David P. | CHIEF BUSINESS OFFICER | 01/30/2020 | 7,996 |
Belloff Neil S. | GENERAL COUNSEL/CORPORATE SECR | 01/30/2020 | 8,469 |
Ward Robert | CHAIRMAN AND CEO | 12/26/2019 | 114,752 |
Ward Robert | CHAIRMAN AND CEO | 09/26/2019 | 45,741 |
Ward Robert | CHIEF EXECUTIVE OFFICER | 06/26/2019 | 94,517 |
Nussbaum Ran | Director | 06/24/2019 | 1,800,000 |
Kariv Tomer | Director | 06/24/2019 | 1,800,000 |
Pontifax Management 4 G.P. (2015) Ltd. | 10% Owner | 06/24/2019 | 1,800,000 |
Ward Robert | CHIEF EXECUTIVE OFFICER | 03/26/2019 | 120,371 |
Ward Robert | CHIEF EXECUTIVE OFFICER | 12/26/2018 | 1,046,279 |
Noiman Silvia | Chief Executive Officer | 06/06/2018 | 210 |
Ward Robert | Chief Executive Officer | 05/22/2018 | 71,700 |
Shabtai Gilad | 10% Owner | 04/30/2018 | 731,250 |
Pontifax Management 4 G.P. (2015) Ltd. | 10% Owner | 04/30/2018 | 3,412,500 |
Nussbaum Ran | Director | 04/30/2018 | 3,412,500 |
Kleijwegt Martijn | Director | 04/30/2018 | 2,925,000 |
Kariv Tomer | Director | 04/30/2018 | 3,412,500 |
Shabtai Gilad | 10% Owner | 04/04/2018 | 24,908 |
Shabtai Gilad | 10% Owner | 04/03/2018 | 53,637 |
Shabtai Gilad | 10% Owner | 03/29/2018 | 43,380 |
Avnur Zafrira | Director | 03/26/2018 | 18,980 |
Ward Robert | Chief Executive Officer | 03/23/2018 | 89,900 |
WEAVER GREGORY L | Chief Financial Officer | 03/23/2018 | 38,520 |
Nussbaum Ran | Director | 03/22/2018 | 48,000 |
Nussbaum Ran | Director | 03/21/2018 | 49,830 |
Kariv Tomer | Director | 03/22/2018 | 48,000 |
Kariv Tomer | Director | 03/21/2018 | 49,830 |
Pontifax Management 4 G.P. (2015) Ltd. | 10% Owner | 03/21/2018 | 49,830 |
Pontifax Management 4 G.P. (2015) Ltd. | 10% Owner | 03/22/2018 | 48,000 |
Avnur Zafrira | Director | 03/21/2018 | 1,999 |
Opko Health, Inc. | 10% Owner | 08/10/2017 | 412,682 |
FROST PHILLIP MD ET AL | Director | 09/29/2015 | 21,350 |
Browne Leslie J | President and CEO | 12/19/2013 | 3,320 |
Browne Leslie J | President and CEO | 05/20/2013 | 1,200 |
FORBES CHRISTOPHER | Director | 11/26/2012 | 400 |
RECTOR DAVID | Director | 11/21/2012 | 5,890 |
FORBES CHRISTOPHER | Director | 08/08/2012 | 1,116,072 |
Waksal Harlan | Director | 08/08/2012 | 223,214 |
Browne Leslie J | President and CEO | 03/29/2012 | 2,600 |
Waksal Harlan | Director | 01/06/2012 | 250,000 |
FORBES CHRISTOPHER | Director | 01/06/2012 | 50,000 |
RECTOR DAVID | Director | 12/07/2011 | 10,402 |
RECTOR DAVID | Director | 06/13/2011 | 5,400 |
FORBES CHRISTOPHER | Director | 03/22/2011 | 4,191 |
Browne Leslie J | President and CEO | 03/21/2011 | 805 |
Browne Leslie J | President and CEO | 02/24/2011 | 865 |
Browne Leslie J | President and CEO | 02/23/2011 | 856 |
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING FOR ELOXX PHARMACEUTICALS INC
STOCK BUYBACKS FOR ELOXX PHARMACEUTICALS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 06/30/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
03/31/2023
2.12%
1Q
12/31/2022
2.13%
2Q
09/30/2022
2.12%
3Q
06/30/2022
2.12%
4Q
03/31/2022
2.13%
5Q
12/31/2021
26.49%
6Q
09/30/2021
2.65%
7Q
06/30/2021
33.30%
8Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ELOXX PHARMACEUTICALS INC
LOADING...